A One Stop Shop for Everything Futures Trading
Whether you're looking to learn the basics of futures or are a seasoned vet looking to hone your trading skills, our Technical Analysis Guide has everything you need to succeed in today's futures markets!
Download your FREE Technical Analysis Trading Guide Today.

DCTH Insider Trading (Delcath Systems)

Insider Ownership Percentage: 16.76%
Insider Buying (Last 12 Months): $585,884.72
Insider Selling (Last 12 Months): $0.00

Delcath Systems Insider Trading History Chart

This chart shows the insider buying and selling history at Delcath Systems by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Delcath Systems Share Price & Price History

Current Price: $4.81
Price Change: Price Increase of +0.3 (6.66%)
As of 08/12/2022 01:00 AM ET

This chart shows the closing price history over time for DCTH up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365
Potential 500% Return From A Unique $1 Asset?
Millions are rushing towards life at “Ground Zero”. 

A frightening new financial reality that has the potential to erase the wealth of millions. It’s largely avoidable if you know what to look for.

It all hinges on a single $1 asset that skyrockets during strange times like these. 

Discover it now
>>>

Delcath Systems Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
7/20/2022Gerard J. MichelCEOBuy62,814$3.98$249,999.72125,864View SEC Filing Icon  
5/16/2022John PurpuraCOOBuy3,300$4.61$15,213.0027,021View SEC Filing Icon  
5/12/2022Steven A. J. SalamonDirectorBuy6,000$4.90$29,400.0029,424View SEC Filing Icon  
4/19/2022Steven A. J. SalamonDirectorBuy1,600$6.25$10,000.00429,100View SEC Filing Icon  
4/18/2022Gerard J. MichelInsiderBuy2,000$6.37$12,740.0063,050View SEC Filing Icon  
4/12/2022Rosalind Advisors, Inc.DirectorBuy2,500$6.48$16,200.00428,000View SEC Filing Icon  
4/11/2022John PurpuraCOOBuy5,000$6.59$32,950.0023,721View SEC Filing Icon  
4/8/2022Gerard J. MichelInsiderBuy2,000$6.57$13,140.0061,050View SEC Filing Icon  
4/6/2022Rosalind Advisors, Inc.DirectorBuy1,000$6.49$6,490.00View SEC Filing Icon  
12/2/2021Gerard J. MichelInsiderBuy23,200$8.61$199,752.00View SEC Filing Icon  
6/30/2021Steven A. J. SalamonDirectorBuy5,500$12.76$70,180.00View SEC Filing Icon  
6/28/2021Gerard J. MichelCEOBuy6,250$11.93$74,562.5029,600View SEC Filing Icon  
6/28/2021Steven A. J. SalamonDirectorBuy5,000$11.56$57,800.00View SEC Filing Icon  
6/25/2021Gerard J. MichelCEOBuy6,600$11.35$74,910.0029,600View SEC Filing Icon  
6/24/2021Steven A. J. SalamonDirectorBuy4,500$10.90$49,050.00View SEC Filing Icon  
5/13/2021John PurpuraCOOBuy4,000$9.42$37,680.0018,713View SEC Filing Icon  
4/5/2021Gerard J. MichelCEOBuy15,500$12.88$199,640.0023,000View SEC Filing Icon  
12/11/2020Gerard J. MichelCEOBuy7,500$13.25$99,375.007,500View SEC Filing Icon  
11/16/2020Gil AharonDirectorBuy2,000$12.00$24,000.00View SEC Filing Icon  
11/13/2020Steven A. J. SalamonDirectorBuy2,000$11.51$23,020.00View SEC Filing Icon  
See Full Table
The Safest Option in Trades!
If you’re new to trading, then you’ve probably heard the wrong thing about options—that they’re risky, unpredictable, or difficult.

And it couldn’t be more wrong! With the Hughes Optioneering Strategy, you’ll soon learn that the safest option for new accounts is options themselves!
Click here now!

SEC Filings (Institutional Ownership Changes) for Delcath Systems (NASDAQ:DCTH)

21.93% of Delcath Systems stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

This chart shows the instiutional buying and selling at DCTH by year and by quarter.

Skip Institutional Buying and Selling Chart and Table DataRead Chart Data in Institutional Trading History Table

Delcath Systems Institutional Trading History

Reporting DateHedge FundShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
8/10/2022Cibc World Market Inc.83,751$0.33M0.0%-5.6%1.059%Search for SEC Filing on Google Icon
5/13/2022Vanguard Group Inc.360,900$2.31M0.0%+5.7%4.563%Search for SEC Filing on Google Icon
5/13/2022Dimensional Fund Advisors LP11,793$75K0.0%N/A0.149%Search for SEC Filing on Google Icon
5/12/2022Cibc World Market Inc.88,751$0.57M0.0%+4.0%1.122%Search for SEC Filing on Google Icon
5/12/2022CI Investments Inc.87,367$0.56M0.0%N/A1.105%Search for SEC Filing on Google Icon
2/15/2022CIBC World Markets Inc.85,319$0.66M0.0%N/A1.160%Search for SEC Filing on Google Icon
11/16/2021Schonfeld Strategic Advisors LLC81,600$0.85M0.0%-6.0%1.109%Search for SEC Filing on Google Icon
11/9/2021BlackRock Inc.13,794$0.14M0.0%-11.6%0.187%Search for SEC Filing on Google Icon
8/16/2021Squarepoint Ops LLC24,773$0.31M0.0%+90.6%0.337%Search for SEC Filing on Google Icon
8/16/2021Schonfeld Strategic Advisors LLC86,800$1.10M0.0%-20.5%1.180%Search for SEC Filing on Google Icon
8/13/2021Northern Trust Corp12,743$0.16M0.0%N/A0.173%Search for SEC Filing on Google Icon
8/13/2021Geode Capital Management LLC58,722$0.74M0.0%+46.6%0.836%Search for SEC Filing on Google Icon
8/12/2021Advisory Services Network LLC3,150$40K0.0%N/A0.045%Search for SEC Filing on Google Icon
5/18/2021Alyeska Investment Group L.P.36,148$0.45M0.0%-27.1%0.559%Search for SEC Filing on Google Icon
5/18/2021Silverarc Capital Management LLC40,000$0.50M0.3%-88.6%0.618%Search for SEC Filing on Google Icon
5/17/2021Schonfeld Strategic Advisors LLC109,235$1.36M0.0%N/A1.688%Search for SEC Filing on Google Icon
5/17/2021Ikarian Capital LLC43,915$0.55M0.0%-61.0%0.679%Search for SEC Filing on Google Icon
5/17/2021Goldman Sachs Group Inc.10,097$0.13M0.0%N/A0.156%Search for SEC Filing on Google Icon
5/13/2021Renaissance Technologies LLC15,900$0.20M0.0%-84.3%0.254%Search for SEC Filing on Google Icon
5/12/2021Geode Capital Management LLC40,044$0.50M0.0%+50.7%0.641%Search for SEC Filing on Google Icon
5/12/2021MYDA Advisors LLC20,000$0.25M0.1%N/A0.320%Search for SEC Filing on Google Icon
2/24/2021Alyeska Investment Group L.P.49,603$0.89M0.0%N/A1.205%Search for SEC Filing on Google Icon
2/18/2021Verition Fund Management LLC30,000$0.54M0.0%N/A0.729%Search for SEC Filing on Google Icon
2/16/2021Silverarc Capital Management LLC351,616$6.30M3.7%N/A8.541%Search for SEC Filing on Google Icon
2/16/2021Squarepoint Ops LLC13,563$0.24M0.0%-45.6%0.329%Search for SEC Filing on Google Icon
2/16/2021Alyeska Investment Group L.P.49,603$0.89M0.0%N/A1.205%Search for SEC Filing on Google Icon
2/16/2021Pura Vida Investments LLC65,000$1.17M0.0%N/A1.579%Search for SEC Filing on Google Icon
2/12/2021AWM Investment Company Inc.87,000$1.56M0.2%N/A2.113%Search for SEC Filing on Google Icon
2/12/2021Ikarian Capital LLC112,712$2.02M0.1%+19.9%2.738%Search for SEC Filing on Google Icon
2/10/2021Renaissance Technologies LLC101,276$1.82M0.0%N/A2.460%Search for SEC Filing on Google Icon
11/16/2020Squarepoint Ops LLC24,931$0.29M0.0%+43.9%0.610%Search for SEC Filing on Google Icon
11/16/2020Worth Venture Partners LLC22,598$0.26M0.2%-11.4%0.553%Search for SEC Filing on Google Icon
11/13/2020Morgan Stanley6,084$71K0.0%+608,300.0%0.149%Search for SEC Filing on Google Icon
8/14/2020Worth Venture Partners LLC25,500$0.26M0.1%N/A0.655%Search for SEC Filing on Google Icon
8/14/2020Ikarian Capital LLC94,000$0.96M0.1%N/A2.414%Search for SEC Filing on Google Icon
8/12/2020Hudson Bay Capital Management LP88,678$0.91M0.0%N/A2.277%Search for SEC Filing on Google Icon
Data available starting January 2016

See Full Table
Delcath Systems logo
Delcath Systems, Inc., an interventional oncology company, focuses on the treatment of primary and metastatic liver cancers in the United States and Europe. The company's lead product candidate is HEPZATO KIT, a melphalan hydrochloride for injection/hepatic delivery system to administer high-dose chemotherapy to the liver while controlling systemic exposure and associated side effects. Its clinical development program for HEPZATO is the FOCUS clinical trial for patients with hepatic dominant ocular melanoma to investigate objective response rate in metastatic ocular melanoma. The company also provides HEPZATO as a stand-alone medical device for sale under the CHEMOSAT Hepatic Delivery System for Melphalan trade name for medical centers to treat a range of liver cancers in Europe. Delcath Systems, Inc. was incorporated in 1988 and is headquartered in New York, New York.
Read More on Delcath Systems

Today's Range

Now: $4.81
Low: $4.47
High: $4.90

50 Day Range

MA: $4.06
Low: $3.62
High: $4.81

52 Week Range

Now: $4.81
Low: $3.49
High: $11.95

Volume

76,346 shs

Average Volume

31,853 shs

Market Capitalization

$41.32 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.93

Who are the company insiders with the largest holdings of Delcath Systems?

Delcath Systems' top insider shareholders include:
  1. Steven A J Salamon (Director)
  2. Rosalind Advisors, Inc (Director)
  3. Gerard J Michel (CEO)
  4. Gerard J Michel (Insider)
  5. John Purpura (COO)
  6. Ernest C Garcia II (Major Shareholder)
  7. Gil Aharon (Director)
Learn More about top insider investors at Delcath Systems.

Who are the major institutional investors of Delcath Systems?

Delcath Systems' top institutional shareholders include:
  1. Cibc World Market Inc. — 1.06%
  2. Concourse Financial Group Securities Inc. — 0.00%
Learn More about top institutional investors of Delcath Systems stock.

Which major investors are selling Delcath Systems stock?

In the last quarter, DCTH stock was sold by these institutional investors:
  1. Cibc World Market Inc.
Tailor an Options Trading Strategy to Fit Your Needs
This guide will help you identify and execute an options trading strategy that fits your specific needs and risk profile.

Take your trading to the next level with the Options Strategy Guide.
Download your FREE Options Strategy Guide Today.